C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/1999
12/28/1999	US6008195 Antimicrobial peptides and methods of use
12/28/1999	US6008194 Human preprotachykinin B
12/28/1999	US6008058 Synthesizing and screening cyclic peptide libraries
12/28/1999	US6008024 An protein which forms an immunological complex with a phosphorylated epitope of an antigen belonging to a paired helical filament-tau protein; diagnosis and therapy for alzheimer's disease
12/28/1999	US6007981 Modifying target cells making them sensative to a toxin; transforming cells with a nucleotide sequences encoding a receptor that binds cryia toxin of bacillus, culturing cells allowing receptor expression on cell surface
12/28/1999	US6007792 Chelate compounds labeled with technetium-99m, rhenium-186, or rhenium-188; tumor imaging
12/28/1999	CA2143163C Peptides derived from a retrovirus of the hiv group, and their use
12/23/1999	WO1999066041A1 94 human secreted proteins
12/23/1999	WO1999065944A1 PEPTIDE INHIBITORS OF αVβ3 AND αVβ¿5?
12/23/1999	WO1999065942A1 Cyclic somatostatin analogs
12/23/1999	WO1999065933A1 Novel cyclosporins
12/23/1999	WO1999065712A2 Glycosulfopeptides and methods of synthesis and use thereof
12/23/1999	WO1999065522A1 Hla binding peptides and their uses
12/23/1999	WO1999065510A1 Crosslink-stabilized indolicidin analogs
12/23/1999	WO1999065508A1 Conformationally constrained backbone cyclized somatostatin analogs
12/23/1999	WO1999065506A2 Cancer therapy with indolicidin or cationic peptides and their polymer conjugates
12/23/1999	WO1999057262A3 Peptide binding to metal ions
12/23/1999	CA2335650A1 Crosslink-stabilized indolicidin analogs
12/23/1999	CA2335184A1 Cyclic somatostatin analogs
12/23/1999	CA2332563A1 Glycosulfopeptides and methods of synthesis and use thereof
12/23/1999	CA2331154A1 Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
12/23/1999	CA2330824A1 Hla binding peptides and their uses
12/22/1999	EP0964868A1 Isolated peptides derived from mage-2
12/22/1999	EP0964867A2 Tachykinin antagonists
12/22/1999	EP0964698A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
12/22/1999	EP0964691A1 Use of conantokins
12/22/1999	EP0964690A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
12/22/1999	EP0726954B1 Cytokine antagonists
12/22/1999	CN1239431A Immunogenic TLP compsn.
12/21/1999	US6004934 Tetrapeptide derivative
12/21/1999	US6004925 Polypeptide anticholesterol agents; cardiovascular disorders, restenosis, atherosclerosis
12/21/1999	US6004906 Plant growth factor
12/21/1999	US6004757 Determining an amino acid sequence motif for a phosphorylation site of a protein kinase
12/21/1999	US6004746 Interaction trap systems for detecting protein interactions
12/21/1999	US6004586 Contacting sperm with purified polypeptide having seqeunce defined in part by truncated portion of prosaposin molecule; contacting sperm with investments of one or more oocytes
12/21/1999	CA1340855C Neurite-promoting factor and process for the manufacture thereof
12/16/1999	WO1999064590A1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1)
12/16/1999	WO1999064442A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999	WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	DE19824959A1 Chemo- or bio-sensor for determining specific analytes
12/16/1999	CA2330247A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999	CA2328500A1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1)
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318745A1 Novel potassium channel drugs and their uses
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/15/1999	CN1238782A Colostrinin and uses thereof
12/15/1999	CN1238781A Heptapeptide oxytocin analofues
12/15/1999	CN1238780A Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
12/15/1999	CA2273683A1 Diagnostic markers for human disorders
12/14/1999	US6001988 High affinity nucleic acid ligands to lectins
12/14/1999	US6001967 Herpes virus proteinase and method of assaying
12/14/1999	US6001964 Peptides which bind to anti-double stranded DNA antibody
12/14/1999	US6001961 Cyclic adhesion inhibitors
12/14/1999	US6001960 Small cyclic peptides which are more stable than endogenous cyclic peptides in the human body and can be used as affinity ligands for g-protein-linked receptors
12/14/1999	US6001815 Depsipeptides containing N-substituted glycine residue
12/14/1999	US6001810 Methods for treating retroviral infection
12/14/1999	US6001805 Administering composition containing fibroblast andkerotinocyte proliferatingly effective amount of antimicrobially effective ampioathic peptide having specified amino acid sequences
12/14/1999	US6001801 Administering antidiabetic agent cyclic peptide to inhibit insulin release in patient
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2065150C Inhibitors of thrombin
12/14/1999	CA2014590C Novel peptides, and antidementia agents containing the same
12/09/1999	WO1999063346A1 Method and device for electrochemical immunoassay of multiple analytes
12/09/1999	WO1999062935A1 Reaction products between carboxylic acid and amino acid or amino acid condensate and process for producing the same
12/09/1999	WO1999062933A2 Rationally designed peptides, production and use thereof
12/09/1999	WO1999062919A1 Redox reversible bipyridyl osmium complex conjugates
12/09/1999	WO1999062918A1 Redox reversible imidazole-osmium complex conjugates
12/09/1999	WO1999062563A2 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors

1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 423